Shares of Acadia Healthcare (ACHC) are down 37c, or 1%, to $40.75 in Monday midday trading following the publications of a New York Times investigation over the weekend that alleged “fraud and fakery” found at Acadia Healthcare’s chain of 165 methadone clinics.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare falsifies records at methadone clinics, NY Times says
- Acadia Healthcare price target lowered to $43 from $76 at Barclays
- Acadia Healthcare price target lowered to $64 from $94 at RBC Capital
- Acadia Healthcare price target lowered to $70 from $91 at TD Cowen
- Acadia Healthcare price target lowered to $45 from $75 at Deutsche Bank